FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/03/083528 [Registered on: 26/03/2025] Trial Registered Prospectively
Last Modified On: 25/03/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Single Arm Study 
Public Title of Study   Respiratory allergy in childhood  
Scientific Title of Study   Establishment Of Childhood Respiratory Allergy Care Centre W.S.R. To Vasa And Kantakari Extract Arosol Nebulization/ Inhalation 
Trial Acronym  Childhood Respiratory Allergy Care Centre-Vasa & Kantakari  
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Nitya Yadav  
Designation  PG STUDENT  
Affiliation  Banaras Hindu University 
Address  Department Of Kaumarbhritya Balroga Faculty Of Ayurveda Institute Of Medical Sciences Banaras Hindu University Varanasi Uttar Pradesh 221005 INDIA

Varanasi
UTTAR PRADESH
221005
India 
Phone  9140281735  
Fax    
Email  ng6739885@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Prem Shanker Upadhyay 
Designation  Associate Professor 
Affiliation  Banaras Hindu University 
Address  Department Of Kaumarbhritya Balroga Faculty Of Ayurveda Institute Of Medical Sciences Banaras Hindu University Varanasi Uttar Pradesh 221005 INDIA

Varanasi
UTTAR PRADESH
221005
India 
Phone  7355422083  
Fax    
Email  upadhyayps1974@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Prem Shanker Upadhyay 
Designation  Associate Professor 
Affiliation  Banaras Hindu University 
Address  Department Of Kaumarbhritya Balroga Faculty Of Ayurveda Institute Of Medical Sciences Banaras Hindu University Varanasi Uttar Pradesh 221005 INDIA

Varanasi
UTTAR PRADESH
221005
India 
Phone  7355422083  
Fax    
Email  upadhyayps1974@gmail.com  
 
Source of Monetary or Material Support  
kaumarbhritya balroga OPD No 25Indian Medicine Wing Sir Sunderlal Hospital IMS BHU 
 
Primary Sponsor  
Name  Banaras Hindu University 
Address  Sir Sunderlal Hospital Institute Of Medical Sciences Banaras Hindu University Varanasi, 221005, Uttar Pradesh, India 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Prem Shanker Upadhyay  Institute Of Medical Sciences, Banaras Hindu University  Department Of Kaumarbhritya Balroga Faculty Of Ayurveda Institute Of Medical Sciences Banaras Hindu University Varanasi Uttar Pradesh 221005 INDIA
Varanasi
UTTAR PRADESH 
07355422083

upadhyayps1974@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee, Institute Of Medical Science, Banaras Hindu University, Varanasi   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:J00||Acute nasopharyngitis [common cold]. Ayurveda Condition: SVASAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Vasa & Kantakari , Reference: Charaka Samhita , Route: Nasal, Dosage Form: Bindu/ Drops (Karna/ Nasa/ Netra), Dose: 0.075(mg), Frequency: bd, Bhaishajya Kal: Sabhakta, Duration: 14 Days, anupAna/sahapAna: No, Additional Information: -
 
Inclusion Criteria  
Age From  5.00 Year(s)
Age To  14.00 Year(s)
Gender  Both 
Details  Age - between 5 yr to 14 years. 2. Sex – both male and female. 3. Mild to moderate case of Respiratory Distress. 4. Case of productive and unproductive cough. 5. Case of acute or chronic cough. 
 
ExclusionCriteria 
Details  Severe case of shwas rog.
Severe pneumonia.
Status asthamaticus.
Cardiac asthma.
Cough which is associated with blood. 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Not Applicable 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
CBC
ESR
IgE
LFT
RFT 
Before intervention
Then after 7 days 
 
Secondary Outcome  
Outcome  TimePoints 
Improvement in criteria in the scale for
Recurrent fever
Respiratory distress
Case of productive & unproductive cough
Respiratory allergy  
FOLLOW UP ON
3days
7days
14days 
 
Target Sample Size   Total Sample Size="100"
Sample Size from India="100" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   11/04/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="2"
Days="1" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Allergic occur when your body misidentifies a harmless substance (called an allergen) as dangerous. Your immune system responds to the false alarm and begins to make antibodies against the allergen. The next time you come in contact with the substance, the antibodies cue the release of allergic chemicals into the bloodstream, resulting in allergic symptoms.

 
Close